Skip to main menu
Skip to main content
Skip to footer
Accessibility Menu
Healthcare Professionals
About Us
Our Team
Leadership Team
Board of Directors
Medical Advisory Board
Careers
Contact Us
Our Product
Science & Technology
Publications
Clinical
Patients
News
Healthcare Professionals
Neurotech Announces Positive Phase 2 Results in NT-501 (CNTF) for Macular Telangiectasia.
Home
ยป
Neurotech Announces Positive Phase 2 Results in NT-501 (CNTF) for Macular Telangiectasia.
View PDF Version
